<div id="readability-page-1">As of April 17, 2026, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI is above 70, according to Benzinga Pro. Here's the latest list of major overbought players in this sector. <h3>Avanos Medical Inc (NYSE:AVNS)</h3> <ul> <li>On April 14, Avanos Medical ( AVNS ) agreed to be acquired by American Industrial Partners for approximately $1.272 billion. Gary Blackford, Avanos Board chair, said, “Our agreement with AIP is a milestone for Avanos that reflects the strong momentum across the business. After careful consideration alongside our independent advisors, we are confident this agreement with AIP represents the right path forward for Avanos and its stockholders. The Board believes this transaction will maximize value for stockholders, create exciting new opportunities for employees, and best position Avanos for long‑term growth and success.” The company's stock gained around 74% over the past five days and has a 52-week high of $24.72.</li> <li>RSI Value: 91.2 </li> <li>AVNS Price Action: Shares of Avanos Medical ( AVNS ) fell 0.2% to close at $24.66 on Thursday.</li> <li>Edge Stock Ratings: 96.31 Momentum score .</li> </ul> &lt;figure class=&#34;wp-block-image size-full is-resized&#34;&gt;<img width="917" height="196" src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/17073529/image-356.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2026/04/17073529/image-356.png"/>&lt;/figure&gt; <h3>Revolution Medicines Inc (NASDAQ:RVMD)</h3> <ul> <li>On April 15, Revolution Medicines ( RVMD ) priced upsized concurrent offerings of 10,563,381 common shares at $142 per share and $500 million convertible notes for $2 billion total proceeds. The company's stock gained around 54% over the past five days and has a 52-week high of $155.70.</li> <li>RSI Value: 83.5</li> <li>RVMD Price Action: Shares of Revolution Medicines ( RVMD ) fell 2.1% to close at $149.27 on Thursday.</li> </ul> Don't miss out on the full BZ Edge Rankings—compare all the key stocks now. Photo via Shutterstock</div>

RVMD

AVNS

LABU

Two health care stocks, Avanos Medical Inc (NYSE:AVNS) and Revolution Medicines Inc (NASDAQ:RVMD), are identified as potentially overbought, with high RSI values indicating a risk of poor short-term performance. Avanos Medical, recently agreeing to be acquired for $1.272 billion, has an RSI of 91.2 and saw a 0.2% drop in stock price. Revolution Medicines, which raised $2 billion through offerings, has an RSI of 83.5 and experienced a 2.1% decline in stock price. Investors should be cautious with these stocks in Q2.

Top 2 Health Care Stocks That May Fall Off A Cliff In Q2